Market Leader Generis Farmacêutica is the leading generic pharmaceutical brand in Portugal, recognized for high consumer trust and the most patient treatments nationwide, presenting strong brand loyalty and market penetration that can be leveraged for expanding product offerings.

Strategic Acquisition As part of the Aurobindo Group and following its acquisition by Aurobindo Pharma USA, Generis benefits from global pharmaceutical expertise, offering opportunities to introduce innovative generics and biosimilars tailored to the Portuguese market.

Growth Potential With a revenue range of $50M to $100M and recent leadership positioning, there is significant potential to scale sales by expanding the portfolio of accessible, cost-effective medications aligned with local healthcare needs.

Technology Integration Utilizing advanced tech tools such as Google Fonts API and ScrollReveal, Generis focuses on digital engagement and technological innovation, creating opportunities to collaborate on digital marketing and e-commerce solutions for pharmaceutical products.

Healthcare Focus Generis’s commitment to contributing to a more sustainable and efficient healthcare system makes it an ideal partner for initiatives aimed at improving access to affordable medicines and expanding distribution networks across Portugal.